ecrin-mdr-crcClinical2018colorectal cancerColorectal CancerInterventionalhttps://newmdr.ecrin.org/Study/2681442China12ECRIN MDRNot yet recruitingfalseA single-center prospective randomized controlled trial for tiggio combined with oxaliplatin (SOX) versus capecitabine combined with oxaliplatin (XELOX) in the treatment of postoperative adjuvant chemotherapy in patients with colorectal cancerInterventions: Group 1:SOX;Group 2:XELOX Primary outcome(s): 3 years disease free survival rate Study Design: Randomized parallel controlled trial2018-12-152681442ChiCTR1800020419